-
1
-
-
70349359435
-
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD)
-
1 Moe, S.M., Drüeke, T.B., Block, G.A., et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 76:Suppl (2009), S1–S130.
-
(2009)
Kidney Int
, vol.76
, pp. S1-S130
-
-
Moe, S.M.1
Drüeke, T.B.2
Block, G.A.3
-
2
-
-
80054992717
-
Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients
-
2 Malluche, H.H., Mawad, H.W., Monier-Faugere, M.C., Renal osteodystrophy in the first decade of the new millennium: analysis of 630 bone biopsies in black and white patients. J Bone Mineral Res 26 (2011), 1368–1376.
-
(2011)
J Bone Mineral Res
, vol.26
, pp. 1368-1376
-
-
Malluche, H.H.1
Mawad, H.W.2
Monier-Faugere, M.C.3
-
3
-
-
84881219688
-
Rapid cortical bone loss in patients with chronic kidney disease
-
3 Nickolas, T.L., Stein, E.M., Dworakowski, E., et al. Rapid cortical bone loss in patients with chronic kidney disease. J Bone Miner Res 28 (2013), 1811–1820.
-
(2013)
J Bone Miner Res
, vol.28
, pp. 1811-1820
-
-
Nickolas, T.L.1
Stein, E.M.2
Dworakowski, E.3
-
4
-
-
84857935918
-
Differences in bone quality in low- and high-turnover renal osteodystrophy
-
4 Malluche, H.H., Porter, D.S., Monier-Faugere, M.C., et al. Differences in bone quality in low- and high-turnover renal osteodystrophy. J Am Soc Nephrol 23 (2012), 525–532.
-
(2012)
J Am Soc Nephrol
, vol.23
, pp. 525-532
-
-
Malluche, H.H.1
Porter, D.S.2
Monier-Faugere, M.C.3
-
5
-
-
33750701135
-
Relationship between moderate to severe kidney disease and hip fracture in the United States
-
5 Nickolas, T.L., McMahon, D.J., Shane, E., Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol 17 (2006), 3223–3232.
-
(2006)
J Am Soc Nephrol
, vol.17
, pp. 3223-3232
-
-
Nickolas, T.L.1
McMahon, D.J.2
Shane, E.3
-
6
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
6 Go, A.S., Chertow, G.M., Fan, D., et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351 (2004), 1296–1305.
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
-
7
-
-
4544229212
-
Increased risk of mortality associated with hip fracture in the dialysis population
-
7 Mittalhenkle, A., Gillen, D.L., Stehman-Breen, C.O., Increased risk of mortality associated with hip fracture in the dialysis population. Am J Kidney Dis 44 (2004), 672–679.
-
(2004)
Am J Kidney Dis
, vol.44
, pp. 672-679
-
-
Mittalhenkle, A.1
Gillen, D.L.2
Stehman-Breen, C.O.3
-
8
-
-
34249653663
-
Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial
-
8 Jamal, S.A., Bauer, D.C., Ensrud, K.E., et al. Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial. J Bone Miner Res 22 (2007), 503–508.
-
(2007)
J Bone Miner Res
, vol.22
, pp. 503-508
-
-
Jamal, S.A.1
Bauer, D.C.2
Ensrud, K.E.3
-
9
-
-
79960028242
-
Effects of denosumab on fracture and bone mineral density by level of kidney function
-
9 Jamal, S.A., Ljunggren, O., Stehman-Breen, C., et al. Effects of denosumab on fracture and bone mineral density by level of kidney function. J Bone Miner Res 26 (2011), 1829–1835.
-
(2011)
J Bone Miner Res
, vol.26
, pp. 1829-1835
-
-
Jamal, S.A.1
Ljunggren, O.2
Stehman-Breen, C.3
-
10
-
-
33845370793
-
Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment
-
10 Miller, P.D., Schwartz, E.N., Chen, P., et al. Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment. Osteoporos Int 18 (2007), 59–68.
-
(2007)
Osteoporos Int
, vol.18
, pp. 59-68
-
-
Miller, P.D.1
Schwartz, E.N.2
Chen, P.3
-
11
-
-
84877641819
-
The relation between renal function and serum sclerostin in adult patients with CKD
-
11 Pelletier, S., Dubourg, L., Carlier, M.C., et al. The relation between renal function and serum sclerostin in adult patients with CKD. Clin J Am Soc Nephrol 8 (2013), 819–823.
-
(2013)
Clin J Am Soc Nephrol
, vol.8
, pp. 819-823
-
-
Pelletier, S.1
Dubourg, L.2
Carlier, M.C.3
-
12
-
-
79955552110
-
Sclerostin and Dickkopf-1 in renal osteodystrophy
-
12 Cejka, D., Herberth, J., Branscum, A.J., et al. Sclerostin and Dickkopf-1 in renal osteodystrophy. Clin J Am Soc Nephrol 6 (2011), 877–882.
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 877-882
-
-
Cejka, D.1
Herberth, J.2
Branscum, A.J.3
-
13
-
-
84856639090
-
Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients
-
13 Cejka, D., Jager-Lansky, A., Kieweg, H., et al. Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients. Nephrol Dial Transpl 27 (2011), 226–230.
-
(2011)
Nephrol Dial Transpl
, vol.27
, pp. 226-230
-
-
Cejka, D.1
Jager-Lansky, A.2
Kieweg, H.3
-
14
-
-
0035282968
-
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
-
14 Balemans, W., Ebeling, M., Patel, N., et al. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum Mol Genet 10 (2001), 537–543.
-
(2001)
Hum Mol Genet
, vol.10
, pp. 537-543
-
-
Balemans, W.1
Ebeling, M.2
Patel, N.3
-
15
-
-
0035089781
-
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
-
15 Brunkow, M.E., Gardner, J.C., Van, N.J., et al. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am J Hum Genet 68 (2001), 577–589.
-
(2001)
Am J Hum Genet
, vol.68
, pp. 577-589
-
-
Brunkow, M.E.1
Gardner, J.C.2
Van, N.J.3
-
16
-
-
77953481395
-
Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
-
16 Ominsky, M.S., Vlasseros, F., Jolette, J., et al. Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength. J Bone Miner Res 25 (2010), 948–959.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 948-959
-
-
Ominsky, M.S.1
Vlasseros, F.2
Jolette, J.3
-
17
-
-
44449099165
-
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
-
17 Li, X., Ominsky, M.S., Niu, Q.T., et al. Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength. J Bone Miner Res 23 (2008), 860–869.
-
(2008)
J Bone Miner Res
, vol.23
, pp. 860-869
-
-
Li, X.1
Ominsky, M.S.2
Niu, Q.T.3
-
18
-
-
84921809759
-
A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density
-
18 Recker, R., Benson, C., Matsumoto, T., et al. A randomized, double-blind phase 2 clinical trial of blosozumab, a sclerostin antibody, in postmenopausal women with low bone mineral density. J Bone Miner Res 30 (2015), 216–224.
-
(2015)
J Bone Miner Res
, vol.30
, pp. 216-224
-
-
Recker, R.1
Benson, C.2
Matsumoto, T.3
-
19
-
-
77954762253
-
Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure
-
19 Nikolov, I.G., Joki, N., Nguyen-Khoa, T., et al. Chronic kidney disease bone and mineral disorder (CKD-MBD) in apolipoprotein E-deficient mice with chronic renal failure. Bone 47 (2010), 156–163.
-
(2010)
Bone
, vol.47
, pp. 156-163
-
-
Nikolov, I.G.1
Joki, N.2
Nguyen-Khoa, T.3
-
20
-
-
0036223869
-
Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7
-
20 Gonzalez, E.A., Lund, R.J., Martin, K.J., et al. Treatment of a murine model of high-turnover renal osteodystrophy by exogenous BMP-7. Kidney Int 61 (2002), 1322–1331.
-
(2002)
Kidney Int
, vol.61
, pp. 1322-1331
-
-
Gonzalez, E.A.1
Lund, R.J.2
Martin, K.J.3
-
21
-
-
0033045019
-
Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone
-
21 Duan, Y., De, L.V., Seeman, E., Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone. J Clin Endocrinol Metab 84 (1999), 718–722.
-
(1999)
J Clin Endocrinol Metab
, vol.84
, pp. 718-722
-
-
Duan, Y.1
De, L.V.2
Seeman, E.3
-
22
-
-
84936064957
-
Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia
-
22 Claramunt, D., Gil-Pena, H., Fuente, R., et al. Chronic kidney disease induced by adenine: a suitable model of growth retardation in uremia. Am J Physiol Renal Physiol 309 (2015), F57–F62.
-
(2015)
Am J Physiol Renal Physiol
, vol.309
, pp. F57-F62
-
-
Claramunt, D.1
Gil-Pena, H.2
Fuente, R.3
-
23
-
-
61349180704
-
Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure
-
23 Lomashvili, K.A., Monier-Faugere, M.C., Wang, X., et al. Effect of bisphosphonates on vascular calcification and bone metabolism in experimental renal failure. Kidney Int 75 (2009), 617–625.
-
(2009)
Kidney Int
, vol.75
, pp. 617-625
-
-
Lomashvili, K.A.1
Monier-Faugere, M.C.2
Wang, X.3
-
24
-
-
0034979016
-
Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat
-
24 Zhou, H., Shen, V., Dempster, D.W., et al. Continuous parathyroid hormone and estrogen administration increases vertebral cancellous bone volume and cortical width in the estrogen-deficient rat. J Bone Miner Res 16 (2001), 1300–1307.
-
(2001)
J Bone Miner Res
, vol.16
, pp. 1300-1307
-
-
Zhou, H.1
Shen, V.2
Dempster, D.W.3
-
25
-
-
84922932317
-
Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy
-
25 Moe, S.M., Chen, N.X., Newman, C.L., et al. Anti-sclerostin antibody treatment in a rat model of progressive renal osteodystrophy. J Bone Miner Res 30 (2015), 499–509.
-
(2015)
J Bone Miner Res
, vol.30
, pp. 499-509
-
-
Moe, S.M.1
Chen, N.X.2
Newman, C.L.3
-
26
-
-
0023833227
-
Characterization of a mouse model of chronic uremia
-
26 Gagnon, R.F., Gallimore, B., Characterization of a mouse model of chronic uremia. Urol Res 16 (1988), 119–126.
-
(1988)
Urol Res
, vol.16
, pp. 119-126
-
-
Gagnon, R.F.1
Gallimore, B.2
-
27
-
-
0942287106
-
Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model
-
27 Lund, R.J., Davies, M.R., Brown, A.J., et al. Successful treatment of an adynamic bone disorder with bone morphogenetic protein-7 in a renal ablation model. J Am Soc Nephrol 15 (2004), 359–369.
-
(2004)
J Am Soc Nephrol
, vol.15
, pp. 359-369
-
-
Lund, R.J.1
Davies, M.R.2
Brown, A.J.3
-
28
-
-
20844459438
-
Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice
-
28 Massy, Z.A., Ivanovski, O., Nguyen-Khoa, T., et al. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice. J Am Soc Nephrol 16 (2005), 109–116.
-
(2005)
J Am Soc Nephrol
, vol.16
, pp. 109-116
-
-
Massy, Z.A.1
Ivanovski, O.2
Nguyen-Khoa, T.3
-
29
-
-
84864152751
-
Repression of osteocyte Wnt/beta-catenin signaling is an early event in the progression of renal osteodystrophy
-
29 Sabbagh, Y., Graciolli, F.G., O'Brien, S., et al. Repression of osteocyte Wnt/beta-catenin signaling is an early event in the progression of renal osteodystrophy. J Bone Miner Res 27 (2012), 1757–1772.
-
(2012)
J Bone Miner Res
, vol.27
, pp. 1757-1772
-
-
Sabbagh, Y.1
Graciolli, F.G.2
O'Brien, S.3
-
30
-
-
84893044528
-
Romosozumab in postmenopausal women with low bone mineral density
-
30 McClung, M.R., Grauer, A., Boonen, S., et al. Romosozumab in postmenopausal women with low bone mineral density. N Engl J Med 370 (2014), 412–420.
-
(2014)
N Engl J Med
, vol.370
, pp. 412-420
-
-
McClung, M.R.1
Grauer, A.2
Boonen, S.3
-
31
-
-
77952992328
-
Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice
-
31 Kramer, I., Loots, G.G., Studer, A., et al. Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J Bone Miner Res 25 (2010), 178–189.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 178-189
-
-
Kramer, I.1
Loots, G.G.2
Studer, A.3
-
32
-
-
77954756294
-
Guidelines for assessment of bone microstructure in rodents using micro-computed tomography
-
32 Bouxsein, M.L., Boyd, S.K., Christiansen, B.A., et al. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 25 (2010), 1468–1486.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 1468-1486
-
-
Bouxsein, M.L.1
Boyd, S.K.2
Christiansen, B.A.3
-
33
-
-
77953520506
-
Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia
-
33 Burghardt, A.J., Kazakia, G.J., Ramachandran, S., et al. Age- and gender-related differences in the geometric properties and biomechanical significance of intracortical porosity in the distal radius and tibia. J Bone Miner Res 25 (2010), 983–993.
-
(2010)
J Bone Miner Res
, vol.25
, pp. 983-993
-
-
Burghardt, A.J.1
Kazakia, G.J.2
Ramachandran, S.3
-
34
-
-
77955845468
-
Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT
-
34 Burghardt, A.J., Buie, H.R., Laib, A., et al. Reproducibility of direct quantitative measures of cortical bone microarchitecture of the distal radius and tibia by HR-pQCT. Bone 47 (2010), 519–528.
-
(2010)
Bone
, vol.47
, pp. 519-528
-
-
Burghardt, A.J.1
Buie, H.R.2
Laib, A.3
-
35
-
-
0003744723
-
Atlas of Mineralzed Bone Histology
-
Karger New York, NY
-
35 Malluche, H.H., Faugere, M.C., Atlas of Mineralzed Bone Histology. 1986, Karger, New York, NY.
-
(1986)
-
-
Malluche, H.H.1
Faugere, M.C.2
-
36
-
-
0019847906
-
A program package for quantitative analysis of histologic structure and remodeling dynamics of bone
-
36 Manaka, R.C., Malluche, H.H., A program package for quantitative analysis of histologic structure and remodeling dynamics of bone. Comput Programs Biomed 13 (1981), 191–201.
-
(1981)
Comput Programs Biomed
, vol.13
, pp. 191-201
-
-
Manaka, R.C.1
Malluche, H.H.2
-
37
-
-
84872866350
-
Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
-
37 Dempster, D.W., Compston, J.E., Drezner, M.K., et al. Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 28 (2013), 2–17.
-
(2013)
J Bone Miner Res
, vol.28
, pp. 2-17
-
-
Dempster, D.W.1
Compston, J.E.2
Drezner, M.K.3
|